IP Library Granted Patent US 8,362,270
Granted Patent B2
US 8,362,270 · App. 12/777,329 · Granted Jan 29, 2013

Self-assembled nanostructures

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,362,270
App. No.
12/777,329
Granted
Jan 29, 2013
Kind
B2
Abstract

An alkylated benzimidazolone compound of the formula: wherein at least one of R 1 to R 4 is X—R c , where X represents a linking group, and R a , R b , and R c independently represents substituted or unsubstituted alkyl groups, provided that at least one of R a and R b represents H. The present disclosure provides alkylated benzimidazolone compounds and self-assembled nanostructures formed from alkylated benzimidazolone compounds.

Claims (69)

1. An alkylated benzimidazolone compound selected from the group consisting of the following compounds:

TABLE 1

Position 5

functional

Sterically Bulky Group(s)

moiety

X

R 1

NH

(CH 2 ) n CH 3 n = 11, 17

NH

NH

NH

X1 = X2 = NH

(CH 2 ) n CH 3 n = 11, 17

X 1 = O X 2 = NH

(CH 2 ) n CH 3 n = 11, 17

N

H

N

H

N

(CH 2 ) n CH 3 n = 3, 11, 17

N

N

N

(CH 2 ) n CH 3 n = 1, 17

N

N

Position 5

functional

Sterically Bulky Group(s)

moiety

R 2

R 3

(CH 2 ) n CH 3 n = 1, 17

(CH 2 ) n CH 3 n = 3, 11, 17

(CH 2 ) n CH 3 n = 1, 17

(CH 2 ) n CH 3 n = 1, 17

TABLE 2

Group X

R c

and mixtures thereof.

2. A nanostructure comprising molecules of the compound according to claim 1 , non-covalently bound to each other.

3. The nanostructure of claim 2 , wherein the non-covalent bonding is predominately through hydrogen-bonding, aromatic pi-pi interactions, and van der Waals' forces.

4. The nanostructure of claim 2 , wherein the nanostructure is formed by homogeneously mixing the compound with a polar or nonpolar liquid under conditions to effect dissolution and self-assembly of the compound.

5. The nanostructure of claim 2 , wherein the nanostructure is a one-dimensional structure in the form of a nanofibril or nanofiber.

6. The nanostructure of claim 2 , wherein the nanostructure is a two-dimensional structure.

7. The nanostructure of claim 2 , wherein the nanostructure is a three-dimensional structure in the form of a non-covalent gelator network or gel.

8. The nanostructure of claim 2 , wherein the nanostructure has, in at least one dimension, a size ranging from about 1 to about 500 nm, and has a largest dimension of up to about 5000 nm.

9. A marking material composition comprising the nanostructure of claim 2 , wherein the marking material is an ink, a toner, a developer, a paint, or a coating.

10. An organogel composition comprising the nanostructure of claim 2 .

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073562/0677 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
RELEASE OF SECURITY INTEREST IN PATENTS AT R/F 062740/0214 Recorded May 18, 2023
From: CITIBANK, N.A., AS AGENT
To: XEROX CORPORATION
Reel/Frame 063694/0122 →
SECURITY INTEREST Recorded Nov 10, 2022
From: XEROX CORPORATION
To: CITIBANK, N.A., AS AGENT
Reel/Frame 062740/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2017
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: XEROX CORPORATION
Reel/Frame 042195/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2010
From: MAKEIFF, DARREN ANDREW; CARLINI, RINA; FENNIRI, HICHAM
To: XEROX CORPORATION; NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 024365/0244 →